Sign in to view content

Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials

Katherine E Talcott, MD

Video
Published 2021

Related

Tarcocimab Tedromer (KSI-301) Anti-VEGF Antibody Biopolymer Conjugate for DME: First-Time Efficacy, Durability and Safety Results of the GLEAM and GLIMMER Phase 3 studies
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2023
Microvascular Changes in the Choriocapillaris of Diabetic Patients Without Retinopathy Investigated by Swept-Source OCT Angiography
Kasra Rezaei, M.D.
On Demand Cases, Courses, and Papers
2020
The Translation of CST to Visual Function: Persistent DME and QOL Measures With FAc Implants in the FAME Study
Michael A. Singer, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more